Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases


You May Also Like

INNATE PHARMA : Outcome of Annual General Meeting of June 2, 2016

MARSEILLE, France, June 3, 2016 (GLOBE NEWSWIRE) -- Innate Pharma (Euronext Paris: FR0010331421 - ...

Progenics Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...